General discussion, page-348

For the Conference Call held on September 19, I submitted the question

By late next year, which product and which end market do you envisage will be the biggest contributors to Alexium revenues?

This was the reply, as per my summary of the Conference Call

Product Share
Organic growth in Alexicool revenues contrasts with stepped growth in Alexiflam NF. Slower progress in the FR market is due to higher levels of regulation. By end of next year it is expected that there will be an approx. 60/40 split between Alexicool and Alexiflam NF.

https://hotcopper.com.au/threads/webcast-september-19.3687060/page-32?post_id=27312894#.WnD-daiWaUk


It was mentioned again (and answered slightly differently) in the October Conference Call, which Taurean7 summarised on October 24.

Breakdown of FR/PCM mix. Currently around 30/70, but FR is expected to balloon in 2HY18 and mix will be around 50/50.

https://hotcopper.com.au/threads/an...756549/page-120?post_id=28145661#.WnD8gqiWaUk